SCHEMBL720720

SCHEMBL720720

CC(=O)N1C(=O)C=CC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 6/20 0.43
GSK3A P49840 2/20 0.43
GSK3B P49841 2/20 0.43
CES1 P23141 1/20 0.39
ALDH1A1 P00352 2/20 0.38
BLM P54132 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
GMNN O75496 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
THPO P40225 1/20 0.38
PMP22 Q01453 1/20 0.38
NOTUM Q6P988 1/20 0.38
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NOX1 Q9Y5S8 1/20 0.37
CYP1A2 P05177 1/20 0.37
HPGD P15428 1/20 0.37
CYP2C19 P33261 1/20 0.37
WRN Q14191 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL711961 0.75 NSD2 (0.41) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL18949795 0.74 MGLL (0.41) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL4857568 0.74 MGLL (0.41) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL12038009 0.74 ALDH1A1 (0.36) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL317849 0.73 DDAH1 (0.39) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL14363033 0.72 ALDH1A1 (0.36) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL2801370 0.71 LMNA (0.43) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL28570540 0.71 P2RX4 (0.37) MGLLGSK3AGSK3BALDH1A1BLM
SCHEMBL3794403 0.70 ALDH1A1 (0.47) MGLLGSK3AGSK3BCES1ALDH1A1
SCHEMBL22893091 0.70 MGLL (0.38) MGLLGSK3AGSK3BALDH1A1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250194586-A1 DISINFECTANT COMPOSITION WHITELEY CORP PTY LTD (AU) 2025-06-19 US claimed
US-12012574-B2 Process for removing dry surface biofilm WHITELEY CORPORATION PTY. LTD. (AU) 2024-06-18 US claimed
CN-117969854-A Kit for detecting cytokine protein concentration and application thereof 国科温州研究院(温州生物材料与工程研究所) 2024-05-03 CN claimed
CN-111818797-A Biofilm removal method 怀特利集团控股有限公司 2020-10-23 CN claimed
EP-3709807-A1 PROCESS FOR REMOVAL OF BIOFILM Whiteley Corporation Pty Ltd (AU) 2020-09-23 EP claimed
US-20190071621-A1 PROCESS FOR REMOVAL OF BIOFILM WHITELEY CORPORATION PTY. LTD. (AU) 2019-03-07 US claimed
US-20170215412-A2 Disinfectant Composition WHITELEY CORPORATION PTY. LTD. (AU) 2017-08-03 US claimed
US-20160270389-A1 Disinfectant Composition WHITELEY CORPORATION PTY. LTD. (AU) 2016-09-22 US claimed
EP-3068222-A1 DISINFECTANT COMPOSITION Whiteley Corporation Pty Ltd (AU) 2016-09-21 EP claimed
CN-104181309-B A kind of highly sensitive Troponin I detection kit SHANDONG BIOBASE BIODUSTRY CO., LTD. (CN) 2016-03-02 CN claimed
WO-2015066760-A1 DISINFECTANT COMPOSITION WHITELEY CORPORATION PTY LTD (AU) 2015-05-14 WO claimed
CN-104181309-A High-sensitivity troponin I detection kit BIOBASE BIODUSTRY SHANDONG CO 2014-12-03 CN claimed
CN-102128915-B Method for diagnosing soil pollution condition by using earthworm biomarkers NANJING UNIVERSITY OF TECHNOLOGY 2013-11-06 CN claimed
CN-102128915-A Method for diagnosing soil pollution condition by using earthworm biomarkers NANJING UNIVERSITY OF TECHNOLOGY 2011-07-20 CN claimed
CN-1164947-C Process for preparing cross-linking antibody by solid-phase immunoadsorption method 中国科学院化工冶金研究所 2004-09-01 CN claimed
CN-1396454-A Process for preparing cross-linking antibody by solid-phase immunoadsorption method CN ACAD INST CHEM METALLURGY (CN) 2003-02-12 CN claimed
US-20260076367-A1 ENDOSCOPE DISINFECTANT WHITELEY CORP PTY LTD (AU) 2026-03-19 US disclosed
WO-2025202647-A1 CDK INHIBITORS CONJUGATED TO EGFR TARGETING MOIETIES KING'S COLLEGE LONDON (GB) 2025-10-02 WO disclosed
CN-1040741-A The method of antiacid fibroblast growth factor complex and treatment gastrointestinal tract ulcerating diseases thereof CHILDRENS MEDICAL CENTER (JP) 1990-03-28 CN disclosed
US-4353734-A PRE- AND POSTEMERGENCE CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA R.T. (HU) 1982-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260076367-A1 ENDOSCOPE DISINFECTANT PMS2, GABBR1, GABRP MGLL 654/4885GSK3A 3463/4885GSK3B 3241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.